New York, USA – February 25, 2025 – Equipped with state-of-the-art aptamer technologies and comprehensive assay kits, Creative Biolabs is about to redefine the way investigators research and intervene in the process of the complement system, part of the body’s immune response that has proved pivotal in an array of life-affecting diseases.
High-quality aptamers represent a tremendous leap in developing molecular recognition. Unlike traditional antibodies, the aptamers provided by Creative Biolabs have several advantages: they are smaller in size, highly stable under a variety of conditions, and can easily be synthesized and modified. This enables fast and cost-effective production, allowing researchers to study such complex biological systems efficiently. Such aptamers increase the accuracy of biological assays and detail the pathway through which diseases develop by binding to the target with antigen specificity and high binding affinity, reaching as low as picomolar.
In detail, Creative Biolabs has developed a robust selection of aptamers for targets within the complement system, including an anti-CD59 aptamer that is used to target the CD59 protein, a marker for cancer stem cells. This enables researchers to isolate and study stem cell-like cancer cell populations.
In addition, Creative Biolabs enhances the power of complement research with its complement assay kits, which attract much attention in drug discovery and preclinical research. These kits boast high specificity and sensitivity for the correct quantification of complement activity. They enable researchers to investigate a range of disease-relevant questions, from assessing immune responses to screening for potential therapeutics. The range encompasses everything from hemolytic assays to ELISA-based functional assay kits and therefore provides a versatile tool for the researcher according to his needs.
The human complement C1q ELISA kit is highlighted at this company for detecting complement C1q in various samples, including plasma, serum, cell culture supernatants, lysates, and tissue homogenates. The kit is valuable for research in autoimmune diseases, inflammatory disorders, and complement-related studies, ensuring reliable performance and reproducible results.
Creative Biolabs also provides custom-made complement assay kits that will help in accomplishing the specific analytical requirements of any researcher.
“We’re pleased to be at the forefront of complement research with our inventive aptamers and all-inclusive assay kits. These products enhance both efficiency and effectiveness in scientific inquiry while providing the critical insights that are required for the development of successful therapeutics,” said a senior scientist at Creative Biolabs.
For more information on Creative Biolabs’ complement therapeutics or to inquire about products, please visit https://www.creative-biolabs.com/complement-therapeutics.
About Creative Biolabs
While continuously developing new technologies, Creative Biolabs is dedicated to offering quality products and services to meet the changing needs of the biotech community. Scientists can now explore the intricacies of the complement system with confidence, supported by superior technology and expertise from Creative Biolabs.
Media ContactCompany Name: Creative BiolabsContact Person: Candy SwiftEmail: Send EmailPhone: 1-631-830-6441Country: United StatesWebsite: https://www.creative-biolabs.com/complement-therapeutics
